Table 3 Phase II results

From: Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer

Response

No. of patients

%

Partial response

12

30

Stable disease

8

20

Progression

20

50

Total

40

100

Back to article page